FN3KRP phosphorylates non-enzymatic glycation adducts, differing from FN3K in substrate specificity:
This dual enzymatic system mitigates advanced glycation end products (AGEs), which accumulate in diabetes and aging .
FN3KRP has emerged as a candidate longevity gene:
rs1046896: A 3’UTR variant linked to longevity in German cohorts. The CC genotype (protective allele) correlates with increased FN3KRP expression in blood and tissues .
Gene-Based Analysis: Multiple SNVs (e.g., rs138953335, rs61743692) contribute to the longevity signal, suggesting cumulative genetic effects .
Gene | SNVs Tested | P-skato (Significance) | Association |
---|---|---|---|
FN3KRP | 5 | 9.19E−06 | Longevity |
PGP | 3 | 2.50E−06 | Longevity |
CDKN2B-AS1 | - | - | Validated longevity locus |
Data derived from exome-wide association studies .
Aging and Metabolic Diseases: FN3KRP overexpression may protect against glycation-driven arterial stiffening and protein dysfunction .
Diabetes: Linked to glycated hemoglobin (HbA1c) regulation; rs1046896-T is a risk allele for HbA1c elevation .
Epistatic Interactions: FN3KRP rs1046896 interacts with HMHA1 rs2074442 (immune response gene) and SET9 rs4097 (epigenetic regulator), suggesting complex genetic networks .
FN3KRP is used in:
FN3KRP (fructosamine-3-kinase-related protein) is a repair enzyme that catalyzes the phosphorylation of psicosamines and ribulosamines on proteins. It plays a crucial role in protein deglycation, which is the reversal of non-enzymatic glycation of proteins. This process helps restore the function of proteins that have been modified by reaction with glucose and other reducing sugars, which can otherwise impair their activity and functionality . FN3KRP is part of a conserved family of repair enzymes present across the Tree of Life and shares detectable sequence similarity to eukaryotic protein kinases .
While FN3KRP and FN3K (fructosamine-3-kinase) are highly similar enzymes encoded by neighboring genes, they exhibit different substrate specificities. Both enzymes contribute to deglycation processes, but FN3KRP preferentially phosphorylates psicosamines and ribulosamines, whereas FN3K has different target substrates. Despite these differences, both enzymes work toward the common goal of restoring protein function by reversing glycation damage .
The human FN3KRP gene is located on chromosome 17, specifically at position 17:80676808-80676926. The gene is also known by aliases including FLJ12171 and FN3KL. Alternative splicing of this gene results in multiple transcript variants . The gene (Entrez Gene ID: 79672) is organized into exonic regions, with validated PCR amplicons spanning these regions to facilitate expression analysis .
Quantitative PCR (qPCR) using SYBR Green technology is a validated approach for measuring FN3KRP expression. According to Bio-Rad's PrimePCR assay validation data, primers targeting an 89bp amplicon within the exonic region of FN3KRP achieve 95% efficiency with high specificity (100%) . The assay demonstrates excellent performance metrics with an R² value of 0.9986 and a cDNA Cq value of 22.19, indicating reliable quantification across a wide dynamic range . When performing gene expression analysis, this design approach helps limit potential unwanted signal from contaminating genomic DNA.
HEK293T cells have been successfully used for transient overexpression of FN3KRP. The protein can be tagged with C-Myc/DDK epitopes for detection and purification purposes . The transfection protocol typically involves using 5μg of ORF cDNA plasmid with appropriate transfection reagents, with cells being cultured for 48 hours post-transfection before collection. For protein extraction, modified RIPA buffer (25mM Tris-HCl pH7.6, 150mM NaCl, 1% NP-40, 1mM EDTA, proteinase inhibitor cocktail, 1mM PMSF, and 1mM Na3VO4) has been effectively used .
CRISPR Knock-Out (KO) HepG2 cell lines have proven valuable for studying FN3KRP function . When developing such models, researchers should consider:
Targeting specific exons that are critical for protein function
Designing guide RNAs with high specificity and minimal off-target effects
Validating knockout efficiency through protein expression analysis
Conducting comprehensive phenotypic characterization using multi-omics approaches (transcriptomics, metabolomics, and interactomics) to fully understand the impact of FN3KRP deletion
An exome-wide association study investigating 62,488 common and rare coding variants in 1,248 German long-lived individuals (including 599 centenarians) and 6,941 younger controls identified a significant association between the SNP rs1046896 in FN3KRP and longevity . This association reached exome-wide significance, positioning FN3KRP as a potential longevity gene. Importantly, the longevity-associated allele C of rs1046896 was linked to increased FN3KRP expression in whole blood, with database analyses confirming this effect across various human tissues .
Based on successful approaches in the literature, researchers investigating FN3KRP's role in longevity should consider a dual analytical strategy:
Single-variant analysis: Examining individual SNPs for direct associations with longevity phenotypes, as was successful in identifying the rs1046896 variant
Gene-based analysis: Considering cumulative effects of common and rare variants within FN3KRP, which can reveal collective genetic influences that might not be detected through single-variant approaches
When conducting replication studies, researchers should be aware that validation may be context-dependent, as evidenced by the successful replication of CDKN2B-AS1 findings but not FN3KRP findings in a French longevity cohort .
FN3KRP may influence longevity through its role in metabolic processes, specifically the reverse glycation of proteins . Glycation, particularly in contexts of elevated glucose levels, can progressively impair protein function by modifying lysine residues. By catalyzing the phosphorylation of glycated proteins, FN3KRP may contribute to maintaining protein homeostasis throughout the lifespan, potentially preventing the accumulation of dysfunctional proteins that could otherwise accelerate aging processes .
Integrative multi-omics analyses have revealed that FN3KRP is associated with several key cellular pathways:
Oxidative stress response mechanisms
Lipid biosynthesis pathways (particularly cholesterol and fatty acid metabolism)
Carbon metabolism
These findings suggest FN3KRP has broader metabolic implications beyond its direct enzymatic function, potentially influencing multiple cellular processes relevant to aging and metabolic health .
Recent research has uncovered intriguing connections between FN3KRP and NAD-mediated processes:
Enrichment of nicotinamide adenine dinucleotide (NAD) binding proteins in FN3KRP interactome studies
Localization of human FN3K to mitochondria
Specific binding of human FN3K to NAD compounds in a metal and concentration-dependent manner
These findings suggest potential roles for FN3KRP in NAD-mediated energy metabolism and redox balance, which are critical processes in cellular health and aging .
FN3KRP expression and function can be modulated by various chemical compounds:
This chemical response profile provides insights into potential environmental modulators of FN3KRP activity relevant to research design and interpretation .
For thorough characterization of FN3KRP's biological roles, researchers should consider an integrated multi-omics approach combining:
Transcriptomics: To identify genes and pathways affected by FN3KRP modulation
Metabolomics: To detect metabolic shifts resulting from altered FN3KRP activity
Interactomics: To map protein-protein interactions and identify binding partners
This integrated approach has successfully revealed connections between FN3KRP and pathways related to oxidative stress response, lipid biosynthesis, and carbon metabolism that would not be apparent through single-omics approaches .
To investigate FN3KRP binding with NAD compounds, researchers should employ a combined computational and experimental approach:
Structural modeling to predict binding interfaces and key interaction residues
Site-directed mutagenesis of predicted critical residues
Binding assays under varying metal ion concentrations, as FN3KRP-NAD interactions show metal dependency
Concentration-dependent binding studies to determine affinity constants
This strategy has proven effective in providing insights into the binding modes between human FN3K and NAD compounds .
The localization of human FN3K to mitochondria suggests several important research directions:
Investigation of FN3KRP's impact on mitochondrial energy production
Examination of potential protective effects against mitochondrial protein glycation
Analysis of FN3KRP's role in mitochondrial redox balance
Assessment of interactions with NAD-dependent mitochondrial processes, including sirtuin activity
These research directions are particularly relevant for understanding FN3KRP's potential therapeutic applications in diabetic complications and metabolic disorders where redox balance and NAD-dependent metabolic processes are altered .
Based on current understanding, FN3KRP presents potential therapeutic targets for:
Diabetic complications, where protein glycation plays a significant pathophysiological role
Metabolic disorders with altered redox balance
Age-related conditions where protein damage accumulation contributes to declining function
Targeting FN3KRP activity or expression could potentially enhance cellular repair mechanisms and maintain protein homeostasis in these conditions .
To advance FN3KRP research, development of the following methodologies would be valuable:
High-throughput screening assays for identifying FN3KRP modulators
Improved tissue-specific knockout models to assess context-dependent functions
Advanced imaging techniques to visualize FN3KRP activity in real-time within living cells
Sensitive methods for detecting and quantifying protein glycation and deglycation events in complex biological samples
When encountering contradictory findings in FN3KRP research, researchers should consider:
Tissue-specific expression patterns of FN3KRP
Genetic background effects on FN3KRP function
Environmental and metabolic context dependencies
Methodological differences in detecting FN3KRP activity or expression
Potential compensatory mechanisms from related enzymes like FN3K
These considerations are particularly important when translating findings between different model systems or populations.
FN3KRP is encoded by the FN3KRP gene. This gene is located on chromosome 17 in humans and is closely related to the fructosamine-3-kinase (FN3K) gene. While FN3K specifically targets fructosamines, FN3KRP has a broader substrate specificity, targeting psicosamines and ribulosamines . The protein consists of 309 amino acids and has a molecular mass of approximately 36 kDa .
The primary function of FN3KRP is to catalyze the phosphorylation of glycated proteins. This phosphorylation leads to the formation of unstable intermediates, which subsequently decompose under physiological conditions, effectively removing the glycated residues from the proteins . This process is essential for maintaining protein function and preventing the accumulation of glycated proteins, which can be detrimental to cellular functions.
FN3KRP’s role in deglycation has significant implications for conditions such as diabetes, where high blood glucose levels lead to increased protein glycation. By removing glycated residues, FN3KRP may help mitigate some of the complications associated with diabetes . Research is ongoing to explore the potential therapeutic applications of FN3KRP in managing diabetic complications and other conditions involving protein glycation.
Recombinant human FN3KRP is produced using Escherichia coli (E. coli) expression systems. The recombinant protein is typically purified to high levels of purity, often exceeding 90%, and is used in various research applications . The recombinant form is also tagged with a His-tag to facilitate purification and detection .
FN3KRP is a subject of extensive research due to its role in protein deglycation. Studies are focused on understanding its mechanism of action, substrate specificity, and potential therapeutic applications. The recombinant form of FN3KRP is used in various assays to study its activity and interactions with other proteins .